Available to Current Clients Only

Prescription Required

Indications
Adequan® i.m. is recommended for the intramuscular treatment of non-infectious degenerative and/or traumatic joint dysfunction and associated lameness of the carpal and hock joints in horses.

As the only FDA-approved equine PSGAG (polysulfated glycosaminoglycan) for degenerative joint disease (DJD) in horses, Adequan® i.m. actually treats degenerative joint disease (DJD), not just its clinical signs. For over 30 years, Adequan® i.m. has been administered by veterinarians to help horses of every discipline and level enjoy greater mobility over their lifetimes.